EMA Releases Pediatric Addendum to Venous Thromboembolism Trial Guidelines
March 1, 2023
The European Medicines Agency (EMA) has created an addendum to its current guidelines on trials of venous thromboembolism (VTE) treatments that is intended to help sponsors expand studies to pediatric populations.